<DOC>
	<DOCNO>NCT01173094</DOCNO>
	<brief_summary>The purpose trial find appropriate way treat DM patient critical limb ischemia . This trial include two part . Part I focus treatment femoral arterial lesion part II focus treatment below-knee arterial lesion .</brief_summary>
	<brief_title>Optimized Strategy Diabetic Patients With Critical Limb Ischemia ( Part II ) ( DCLI-II )</brief_title>
	<detailed_description>The trial include two part part II . This part multi-center , prospective , registration study focus treatment below-knee arterial lesion . Totally 130 patient entered part . They suffer ischemic symptom Rutherford 3-6 occlusion below-knee artery ( anterior tibial、posterior tibial peroneal artery ) . According lesion length , patient accept transluminal angioplasty below-knee arterial bypass . They follow 3 year . Study examinations do screening , procedure time , 1 , 6 , 12 , 24 36 month procedure .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>The patient volunteer join trial sign formal consent . The patient ≥55 yearold ≤75 yearold . The patient suffer symptomatic leg ischemia rutherford classification3 , 4 , 5 6 . Obvious stenosis occlusion belowknee popliteal artery No obvious stenosis occlusion aortoiliac artery ; lesion could treat simultaneously already cure . No surgical contraindication ; infection operation region . Be diagnose DM least 1 year . Refuse random treatment . Previous operation target artery . Acute low extremity arterial thrombosis . Serious major organ failure . Allergic contrast agent contrast nephropathy . No clinical compliance unfit join trial</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Critical limb ischemia</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Diabetes foot</keyword>
</DOC>